Early COVID treatment trial halted before launch
NCT ID NCT04356677
Summary
This early-stage study aimed to test whether inhaled Virazole (ribavirin) could help hospitalized adults with COVID-19 who were experiencing serious breathing problems. The trial planned to measure whether the treatment improved patients' breathing and overall condition. However, the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.